Jonathan Goodman, MPhil

Among pediatric patients with cerebral venous thrombosis, treatment with rivaroxaban or standard anticoagulants resulted in a similarly reduced risk for recurrent VTE or bleeding.

Cerebral MRI data suggest that neurological symptoms and cognitive impairment may be common among patients with an acute TTP event.